• Product NameDexibuprofen
• Brief DescriptionInhibitors
• Purification99.00%
• Biological ActivityS(+)-Ibuprofen is capable of inhibiting cyclooxygenase (COX) at clinically relevant concentrations, R(-)-ibuprofen is not a COX inhibitor.
• Target NameBcr-Abl antagonist; COX inhibitor; Cysteine Protease antagonist; PPAR activator; Thrombin inhibitor
• CAS No. 51146-56-6
• Calculated MW 206.28
• Formulation C13H18O2
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Nervous system
  SMILES:C[C@@H](C1=CC=C(C=C1)CC(C)C)C(=O)O
  Pathways:Angiogenesis; Immunology/Inflammation; Metabolism; Others; Proteases/Proteasome; Cytoskeletal Signaling; Neuroscience
  Receptor:Bcl-2; COX; Cystic fibrosis transmembrane conductance regulator; PPARγ; thrombomodulin
  Boling pt:319.6C?
  Melting pt:49-53C
  Solubility:Soluble in DMSO
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Sanchez-Fidalgo S, et al. Eur J Pharmacol. 2004 Nov 28; 505(1-3):187-94.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting